David Matly currently serves as the VP of Business Development at Chrono Therapeutics, an early-stage pharmaceutical company that is fully integrating digital health into its drug offerings. David is responsible for all corporate partnering activities as well as leading the expansion of Chrono's platform technology into new therapeutic areas. David brings to Chrono many years of commercial leadership experience at Eli Lilly where he worked across diabetes, cardiovascular, and oncology therapeutic areas. Most recently, he was responsible for the launch of Eli Lilly's newest oncology therapy. David holds a BS in engineering from Purdue University and an MBA from Harvard.
10:15 AM–11:15 AM Jun 22, 2017 (America - Los Angeles)
Room 6EF, Upper Level